2-Naphthalenecarboxylic acid, 3-hydroxy-, 2-[(2,4,5-trihydroxyphenyl)Methylene]hydrazide – (1256493-34-1)

Cerdulatinib hydrochloride, 1369761-01-2, Cerdulatinib HCl, Cerdulatinib HCl salt, RVT-502 hydrochloride, L1KRM66Y4X, PRT062070, 4-(cyclopropylamino)-2-[4-(4-ethylsulfonylpiperazin-1-yl)anilino]pyrimidine-5-carboxamide hydrochloride, UNII-L1KRM66Y4X, Cerdulatinib (hydrochloride), 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide (hydrochloride), 5-Pyrimidinecarboxamide, 4-(cyclopropylamino)-2-((4-(4-(ethylsulfonyl)-1-piperazinyl)phenyl)amino)-, hydrochloride (1:1), 4-(Cyclopropylamino)-2-((4-(4-(ethylsulfonyl)piperazin-1-yl)phenyl)amino)pyrimidine-5-carboxamide hydrochloride, Cerdulatinib (PRT062070, PRT2070), CHEMBL3991929, Cerdulatinib HCl pound>>PRT2070, BCP25893, HY-15999A, s7634, AKOS032945147, CCG-269563, AC-35809, BS-15309, Cerdulatinib(PRT-062070 PRT2070), Cerdulatinib(PRT-062070 PRT2070)?, CS-0010193, C72485, PRT062070 hydrochloride PRT2070 hydrochloride